Cathy Tralau-Stewart joins expert panel at 2025 Drug Discovery World Symposium
Milner Executive Director Cathy Tralau-Stewart was delighted to join Drug Discovery World (DDW) at their 2025 Symposium this month, which brought together leaders from drug discovery, academia, and biotech to explore how innovation can move more effectively from...
Milner Therapeutics Institute and Cambridge Network join forces to showcase MTI partnerships and enterprise
Earlier this week, we were delighted to team up with Cambridge Network to host an event at the West Hub in Cambridge. The event provided an overview of the Institute’s unique translational ecosystem, and Cambridge Network members gathered to learn more about the ways...
Milner Institute joins BioCentury’s Grand Rounds Europe conference
The Milner Institute was proud to take part in BioCentury’s Grand Rounds Europe conference in Cambridge this month. Over three days of keynotes, fireside chats, panel discussions and networking sessions, Grand Rounds fostered meaningful dialogue, inspired new ideas,...
Daiichi Sankyo joins Milner Therapeutics Consortium
We are delighted to announce that Daiichi Sankyo has joined the Milner Therapeutics Consortium as our tenth pharma partner. The Milner team works closely with this unique grouping of pharma companies to advance research towards new therapeutics across multiple disease...